Order by 12pm AEDT, Monday to Friday, for same-day shipping!

Ipamorelin (5mg)

$119.00

9 in stock (can be backordered)

By Buying 

3 Bottles

You can get 10% off

By Buying 

6 Bottles

You can get 15% off

By Buying 

9 Bottles

You can get 20% off

To get a discount, simply add products to the cart and continue to the checkout page, and the discount will automatically be applied.

Ipamorelin: Growth Hormone Secretagogue for Endocrine and Metabolic Research

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue studied for its ability to selectively stimulate growth hormone (GH) release from the anterior pituitary gland. It functions through activation of the ghrelin receptor (GHS-R1a), mimicking endogenous ghrelin signalling while maintaining a high degree of specificity for GH secretion. Unlike earlier growth hormone releasing peptides, Ipamorelin has been characterised by its minimal interaction with cortisol, prolactin, and other pituitary hormones, making it a compound of interest in research focused on targeted GH modulation and endocrine balance. Research into Ipamorelin examines its role in growth hormone pulsatility, tissue repair pathways, body composition regulation, and metabolic signalling. Due to its selective receptor profile, Ipamorelin is frequently studied as a comparator compound alongside other GH secretagogues and GHRH analogues.

Product Summary Table

Peptide Name Ipamorelin
Peptide Class Growth hormone secretagogue (GHS)
Primary Target Ghrelin receptor (GHS-R1a)
Mechanism of Action Selective stimulation of pituitary growth hormone release
Amino Acid Length 5 amino acids (pentapeptide)
Form Lyophilised synthetic peptide (must be reconstituted)
Research Vial Format 5 mg
Country of Origin Australia
Storage Lyophilised: store cold and protected from light; Reconstituted: 2–8°C
Standard Research Grade Purity ≥98 percent

In Vivo Research Findings

Ipamorelin has been evaluated in preclinical and clinical research models examining growth hormone dynamics and endocrine signalling.
  • Selective growth hormone release with minimal impact on cortisol and prolactin levels.
  • Preservation of natural GH pulsatility rather than continuous hormone elevation.
  • Support of tissue repair pathways associated with GH and IGF-1 signalling.
  • Metabolic regulation involving lipid mobilisation and protein synthesis pathways.
  • Favourable tolerability profile compared to earlier GHS compounds.

Research Applications of Ipamorelin

  • Endocrine Research focused on pituitary growth hormone regulation.
  • GH–IGF Axis Investigation in metabolic and ageing models.
  • Tissue Repair Studies involving connective tissue and muscle signalling.
  • Comparative Secretagogue Research alongside GHRH analogues and other GHS compounds.
  • Body Composition Research examining GH-mediated pathways.

Studies and Additional Info

  • Clinical endocrinology research on ghrelin receptor agonists
  • Studies examining Ipamorelin-induced GH release dynamics
  • Comparative analyses with GHRP-2, GHRP-6, and GHRH analogues
  • Research into selective pituitary hormone modulation
Disclaimer: Ipamorelin 5mg is supplied strictly for laboratory research purposes. It is not intended for human consumption or therapeutic use.

Frequently Asked Questions

What is Ipamorelin studied for?

Ipamorelin is studied for its ability to selectively stimulate growth hormone release via ghrelin receptor activation.

Does Ipamorelin directly contain growth hormone?

No. Ipamorelin does not contain GH; it stimulates endogenous GH release from the pituitary gland.

How does Ipamorelin differ from other GHRPs?

Ipamorelin is more selective for GH release and shows minimal stimulation of cortisol or prolactin compared to earlier compounds.

Is Ipamorelin a hormone?

No. Ipamorelin is a peptide secretagogue that influences hormone release rather than acting as a hormone itself.

Is Ipamorelin approved for human use?

No. Ipamorelin is supplied strictly for laboratory research purposes and is not approved for human consumption.

    Which product’s lab result would you like to receive?

    Our RAD140 3rd party lab test will be emailed to you once submitted.

    Our RAD150 3rd party lab test will be emailed to you once submitted.

    Our MK677 3rd party lab test will be emailed to you once submitted.

    Our MK2866 3rd party lab test will be emailed to you once submitted.

    Our SR9009 3rd party lab test will be emailed to you once submitted.

    Our LGD4033 3rd party lab test will be emailed to you once submitted.

    Our S4 3rd party lab test will be emailed to you once submitted.

    Our S23 3rd party lab test will be emailed to you once submitted.

    Our GW0742 3rd party lab test will be emailed to you once submitted.

    Our GW501516 3rd party lab test will be emailed to you once submitted.

    Our YK11 3rd party lab test will be emailed to you once submitted.

    Our GHRP-2 3rd party lab test will be emailed to you once submitted.

    Our CJC-1295 with DAC 3rd party lab test will be emailed to you once submitted.

    Our TB-500 3rd party lab test will be emailed to you once submitted.

    Our BPC-157 3rd party lab test will be emailed to you once submitted.

    Our GHRP-6 3rd party lab test will be emailed to you once submitted.

    Our HGH 12IU 3rd party lab test will be emailed to you once submitted.

    Our HCG 3rd party lab test will be emailed to you once submitted.

    Our PT-141 3rd party lab test will be emailed to you once submitted.

    Our SHK-CU 3rd party lab test will be emailed to you once submitted.

    Our Ipamorelin 3rd party lab test will be emailed to you once submitted.

    Our Retatutide 3rd party lab test will be emailed to you once submitted.

    Our Tizepatide 3rd party lab test will be emailed to you once submitted.

    Our MELANOTAN II 3rd party lab test will be emailed to you once submitted.

    Our Tesamorelin 3rd party lab test will be emailed to you once submitted.

    Our MOTS-c 3rd party lab test will be emailed to you once submitted.

    This is a test group.

    Description

    Ipamorelin: Growth Hormone Secretagogue for Endocrine and Metabolic Research

    Ipamorelin is a synthetic pentapeptide growth hormone secretagogue studied for its ability to selectively stimulate growth hormone (GH) release from the anterior pituitary gland. It functions through activation of the ghrelin receptor (GHS-R1a), mimicking endogenous ghrelin signalling while maintaining a high degree of specificity for GH secretion. Unlike earlier growth hormone releasing peptides, Ipamorelin has been characterised by its minimal interaction with cortisol, prolactin, and other pituitary hormones, making it a compound of interest in research focused on targeted GH modulation and endocrine balance.

    Research into Ipamorelin examines its role in growth hormone pulsatility, tissue repair pathways, body composition regulation, and metabolic signalling. Due to its selective receptor profile, Ipamorelin is frequently studied as a comparator compound alongside other GH secretagogues and GHRH analogues.

    Product Summary Table

    Peptide Name Ipamorelin
    Peptide Class Growth hormone secretagogue (GHS)
    Primary Target Ghrelin receptor (GHS-R1a)
    Mechanism of Action Selective stimulation of pituitary growth hormone release
    Amino Acid Length 5 amino acids (pentapeptide)
    Form Lyophilised synthetic peptide (must be reconstituted)
    Research Vial Format 5 mg
    Country of Origin Australia
    Storage Lyophilised: store cold and protected from light; Reconstituted: 2–8°C
    Standard Research Grade Purity ≥98 percent

    In Vivo Research Findings

    Ipamorelin has been evaluated in preclinical and clinical research models examining growth hormone dynamics and endocrine signalling.

    • Selective growth hormone release with minimal impact on cortisol and prolactin levels.
    • Preservation of natural GH pulsatility rather than continuous hormone elevation.
    • Support of tissue repair pathways associated with GH and IGF-1 signalling.
    • Metabolic regulation involving lipid mobilisation and protein synthesis pathways.
    • Favourable tolerability profile compared to earlier GHS compounds.

    Research Applications of Ipamorelin

    • Endocrine Research focused on pituitary growth hormone regulation.
    • GH–IGF Axis Investigation in metabolic and ageing models.
    • Tissue Repair Studies involving connective tissue and muscle signalling.
    • Comparative Secretagogue Research alongside GHRH analogues and other GHS compounds.
    • Body Composition Research examining GH-mediated pathways.

    Studies and Additional Info

    • Clinical endocrinology research on ghrelin receptor agonists
    • Studies examining Ipamorelin-induced GH release dynamics
    • Comparative analyses with GHRP-2, GHRP-6, and GHRH analogues
    • Research into selective pituitary hormone modulation

    Disclaimer: Ipamorelin 5mg is supplied strictly for laboratory research purposes. It is not intended for human consumption or therapeutic use.

    Frequently Asked Questions

    What is Ipamorelin studied for?

    Ipamorelin is studied for its ability to selectively stimulate growth hormone release via ghrelin receptor activation.

    Does Ipamorelin directly contain growth hormone?

    No. Ipamorelin does not contain GH; it stimulates endogenous GH release from the pituitary gland.

    How does Ipamorelin differ from other GHRPs?

    Ipamorelin is more selective for GH release and shows minimal stimulation of cortisol or prolactin compared to earlier compounds.

    Is Ipamorelin a hormone?

    No. Ipamorelin is a peptide secretagogue that influences hormone release rather than acting as a hormone itself.

    Is Ipamorelin approved for human use?

    No. Ipamorelin is supplied strictly for laboratory research purposes and is not approved for human consumption.

    Reviews

    There are no reviews yet.

    Be the first to review “Ipamorelin (5mg)”

    Your email address will not be published. Required fields are marked *